Form 4 for BMRN BIOMARIN PHARMACEUTICAL INC
Accepted 2023-12-12 00:00:00 ET · period of report 2023-10-04 · accession 0001048477-23-000057 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-12-12 | 2023-10-04 | BMRN | BIENAIME JEAN JACQUES | Dir | L - Small Acq | $85.57 | +10 | 422.7K | +0.0% | +$855.70 | |
| 2023-12-12 | 2023-12-01 | BMRN | BIENAIME JEAN JACQUES | Dir | A - Grant | $0.00 | +2,370 | 425.1K | +0.6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-10-04 | L | A | 10 | $85.57 | 422,742 | D | — | — | (F1) The sale reported in this Form 4 was matchable under Section 16(b) of the Securities Exchange Act of 1934, as amended, to the extent of 10 shares, with the reporting person's sale of shares at a price of $99.56 on April 10, 2023. The reporting person has agreed to pay to the Issuer the full amount of the profit realized by the reporting person in connection with the short-swing transaction, less transaction costs. |
| 2 | Common | Common Stock | 2023-12-01 | A | A | 2,370 | $0.00 | 425,112 | D | — | — | (F2) Restricted stock units granted on December 1, 2023. Price not applicable. |